908 Devices 

$6.22
26
+$0.1+1.63% Today

Statistics

Day High
6.36
Day Low
6.17
52W High
9.34
52W Low
3.55
Volume
107,984
Avg. Volume
314,593
Mkt Cap
225.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.84
-0.56
-0.27
0.01
Expected EPS
-0.15
Actual EPS
N/A

Financials

-121.09%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
119.26MRevenue
-144.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MASS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of analytical instruments and services that compete with 908 Devices' mass spectrometry solutions.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies provides comprehensive analytical instruments, including mass spectrometry, which directly competes with 908 Devices' offerings.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation, through its subsidiaries, offers mass spectrometry and analytical technologies that compete with 908 Devices' products.
Waters
WAT
Mkt Cap20.81B
Waters Corporation specializes in analytical instruments, including mass spectrometry, making it a direct competitor to 908 Devices.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation offers a range of analytical instruments and solutions, including mass spectrometry, that compete with 908 Devices.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories provides a variety of instruments and software for the life science research and clinical diagnostics markets, competing in areas similar to 908 Devices.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences, while more focused on medical devices and surgical instruments, competes with 908 Devices in the healthcare and life sciences sector.
Repligen
RGEN
Mkt Cap8.39B
Repligen Corporation provides bioprocessing technologies and solutions that, while not directly competing in mass spectrometry, serve similar end markets as 908 Devices.
Bio-Techne
TECH
Mkt Cap9.74B
Bio-Techne, through its analytical and diagnostic products, competes in the broader life sciences market, overlapping with some of 908 Devices' target markets.

About

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Show more...
CEO
Dr. Kevin J. Knopp Ph.D.
Employees
246
Country
US
ISIN
US65443P1021

Listings

0 Comments

Share your thoughts

FAQ

What is 908 Devices stock price today?
The current price of MASS is $6.22 USD — it has increased by +1.63% in the past 24 hours. Watch 908 Devices stock price performance more closely on the chart.
What is 908 Devices stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange 908 Devices stocks are traded under the ticker MASS.
Is 908 Devices stock price growing?
MASS stock has fallen by -0.47% compared to the previous week, the month change is a -8.84% fall, over the last year 908 Devices has showed a +54.55% increase.
What is 908 Devices market cap?
Today 908 Devices has the market capitalization of 225.12M
When is the next 908 Devices earnings date?
908 Devices is going to release the next earnings report on May 12, 2026.
What were 908 Devices earnings last quarter?
MASS earnings for the last quarter are 0.01 USD per share, whereas the estimation was -0.07 USD resulting in a +114.18% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 908 Devices revenue for the last year?
908 Devices revenue for the last year amounts to 119.26M USD.
What is 908 Devices net income for the last year?
MASS net income for the last year is -144.41M USD.
How many employees does 908 Devices have?
As of April 01, 2026, the company has 246 employees.
In which sector is 908 Devices located?
908 Devices operates in the Health Care sector.
When did 908 Devices complete a stock split?
908 Devices has not had any recent stock splits.
Where is 908 Devices headquartered?
908 Devices is headquartered in Boston, US.